Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Experimental Physiology 93.5 pp 519-527
DOI: 10.1113/expphysiol.2008.042002
© The Physiological Society 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/5/519    most recent
expphysiol.2008.042002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Santos, R. A. S.
Right arrow Articles by Simões e Silva, A. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santos, R. A. S.
Right arrow Articles by Simões e Silva, A. C.
Related Collections
Right arrow Review Articles
Right arrow Cardiovascular control

Review Articles

Recent advances in the angiotensin-converting enzyme 2–angiotensin(1–7)–Mas axis

Robson A. S. Santos1, Anderson J. Ferreira2 and Ana Cristina Simões e Silva3

Departments of 1 Physiology and Biophysics2 Morphology3 Pediatrics, Federal University of Minas Gerais, Belo Horizonte, MG, 31.270-901, Brazil

In the past few years, the classical concept of the renin–angiotensin system (RAS) has experienced substantial conceptual changes. The identification of: the renin/prorenin receptor; the angiotensin-converting enzyme homologue, ACE2, as an angiotensin peptide-processing enzyme and a virus receptor for severe acute respiratory syndrome, the Mas as a receptor for angiotensin (1–7) [Ang(1–7)], and the possibility of signaling through ACE have contributed to switch our understanding of the RAS from the classical limited-proteolysis linear cascade to a cascade with multiple mediators, multiple receptors and multifunctional enzymes. With regard to Ang(1–7), the identification of ACE2 and of Mas as a receptor implicated in its actions contributed to decisively establish this heptapeptide as a biologically active member of the RAS cascade. In this review, we will focus on the recent findings related to the ACE2–Ang(1–7)–Mas axis and, in particular, on its putative role as an ACE–Ang II–AT1 receptor counter-regulatory axis within the RAS.

(Received 8 January 2008; accepted after revision 26 February 2008; first published online 29 February 2008)
Corresponding author: R. A. S. Santos: Departamento de Fisiologia e Biofísica, Avenida Antônio Carlos, 6627 – ICB – UFMG, 31 270-901 – Belo Horizonte, MG, Brasil. Email: marrob{at}dedalus.lcc.ufmg.br




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. Stewart, I. Taneja, N. Raghunath, D. Clarke, and M. S. Medow
Intradermal angiotensin II administration attenuates the local cutaneous vasodilator heating response
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H327 - H334.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
M. K. Raizada and J. F. R. Paton
Recent advances in the renin-angiotensin system: angiotensin-converting enzyme 2 and (pro)renin receptor
Exp Physiol, May 1, 2008; 93(5): 517 - 518.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the The Physiological Society.